We have located links that may give you full text access.
Comparative Study
Journal Article
Effect of sex in branch retinal vein occlusion.
European Journal of Ophthalmology 1998 January
PURPOSE: To evaluate the effect of sex in relation to crossing numbers, arterial overcrossings and occlusion sites in patients with branch retinal vein occlusion (BRVO).
METHODS: Fifty-one eyes with BRVO (study group) and 48 eyes with retinal problems other than BRVO (control group) were investigated. All venous occlusions were examined in detail with regard to their anatomical positions, sites and arteriovenous crossings on the retinal surrounding area two disc diameters nasally, four disc diameters temporally, three disc diameters superiorly and three inferiorly from the optic disc, in the arteriovenous phase of fundus fluorescein angiography and fundus color photography.
RESULTS: The study group comprised 29 women (56.86%) and 22 men (43.14%). All occlusions were unilateral and located at the crossing areas. BRVO had arterial overcrossing in 28 eyes (96.6%) in females and 22 eyes (95.5%) in males (p>0.005). The average numbers of crossings were 7.79 +/- 1.57 in females and 7.82 +/- 1.05 in males in the study group (p>0.05), and respectively 7.30 +/- 1.19 and 6.95 +/- 1.13 (p>0.05) in the control group. The average arterial overcrossing ratios were 75% in females and 71% in males in the study group (p>0.05), and 74% and 65% in the control group (p<0.05).
CONCLUSIONS: Our data suggest that females have a higher risk than males because of their arterial overcrossing ratio and BRVO prefer arterial overcrossing. However the insignificant difference between the female and male patients leads us to assume that the effect of sex on BRVO cannot be explained only by local anatomical factors since their effect is only slight.
METHODS: Fifty-one eyes with BRVO (study group) and 48 eyes with retinal problems other than BRVO (control group) were investigated. All venous occlusions were examined in detail with regard to their anatomical positions, sites and arteriovenous crossings on the retinal surrounding area two disc diameters nasally, four disc diameters temporally, three disc diameters superiorly and three inferiorly from the optic disc, in the arteriovenous phase of fundus fluorescein angiography and fundus color photography.
RESULTS: The study group comprised 29 women (56.86%) and 22 men (43.14%). All occlusions were unilateral and located at the crossing areas. BRVO had arterial overcrossing in 28 eyes (96.6%) in females and 22 eyes (95.5%) in males (p>0.005). The average numbers of crossings were 7.79 +/- 1.57 in females and 7.82 +/- 1.05 in males in the study group (p>0.05), and respectively 7.30 +/- 1.19 and 6.95 +/- 1.13 (p>0.05) in the control group. The average arterial overcrossing ratios were 75% in females and 71% in males in the study group (p>0.05), and 74% and 65% in the control group (p<0.05).
CONCLUSIONS: Our data suggest that females have a higher risk than males because of their arterial overcrossing ratio and BRVO prefer arterial overcrossing. However the insignificant difference between the female and male patients leads us to assume that the effect of sex on BRVO cannot be explained only by local anatomical factors since their effect is only slight.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app